5 results match your criteria: "Centre Hospitalier Sud Seine-et-Marne[Affiliation]"
J Clin Nurs
July 2024
Universite Paris Cite, INSERM, Paris, France.
Aims: To identify and describe nursing practices on the sexual health of people with neurological disorders.
Design: Narrative review.
Methods: Data were extracted from 1 January 2002, to 20 May 2021.
J Oral Implantol
April 2023
Faculty of Medicine, University Paris-Est-Créteil and Pain Center, Centre Hospitalier Sud Seine-et-Marne, Nemours, France.
The objective of this study is to establish an algorithm for the medicosurgical treatment of dental implant-induced neuropathic pain. The methodology was based on the good practice guidelines from the French National Authority for Health: the data were searched on the Medline database. A working group has drawn up a first draft of professional recommendations corresponding to a set of qualitative summaries.
View Article and Find Full Text PDFJ Immunol Res
March 2022
Public Health Unit, Groupe Hospitalier Sud Ile de France, Melun, France.
Introduction: The risk of extended spectrum -lactamase (ESBL) bacterial acquisition in patients with -lactam allergy has been poorly investigated. In a previous study conducted over a 6-year long period (2007-2012), we found that patients with declared -lactam allergy had a higher risk of ESBL bacterial carriage at admission in intensive care unit (ICU), but they had not a higher risk of ESBL bacterial acquisition. We present the final results of the study which was eventually conducted over a 12-year long period (2007-2018).
View Article and Find Full Text PDFCrit Care
February 2021
Assistance Publique - Hôpitaux de Paris (AP-HP), Service de médecine intensive et réanimation, Hôpital Saint-Antoine, 184 rue du Faubourg Saint-Antoine, 75571, Paris Cedex 12, France.
Int J Antimicrob Agents
July 2020
Infectious Diseases Unit, Groupe Hospitalier Sud Ile de France, Melun, France; Internal Medicine Unit, Groupe Hospitalier Sud Ile de France, Melun, France.
Patients identified as allergic to β-lactams are frequently exposed to treatment with broad-spectrum antibiotics. However, the risk of carriage of extended-spectrum β-lactamase (ESBL)-producing isolates in this population has been poorly investigated. The aim of this study was to evaluate the characteristics and clinical outcomes of patients admitted to the intensive care unit (ICU) with and without declared β-lactam allergy at admission.
View Article and Find Full Text PDF